P. Piso

发表

IGF-1R, IGF-1 and IGF-2 expression as potential prognostic and predictive markers in colorectal-cancer

C. Langner, J. Rüschoff, H. Kreipe, 2003, Virchows Archiv.

A novel tumor‐node‐metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi‐institutional database *

T. Chua, D. Morris, P. Piso, 2011, Cancer.

Importance of gender in diffuse malignant peritoneal mesothelioma.

T. Chua, D. Morris, P. Piso, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Cytoreductive surgery after recurrent epithelial ovarian cancer and at other timepoints

P. Piso, P. Sammartino, T. Cornali, 2013 .

Who is willing to take the risk? Assessing the readiness for living liver donation in the general German population

P. Piso, A. Obed, F. Popp, 2006, Journal of Medical Ethics.

Morbidity and mortality associated with pancreatogastrostomy and pancreatojejunostomy following partial pancreatoduodenectomy

H. Schlitt, P. Piso, M. Neipp, 2002, The British journal of surgery.

Prognostic Significance of Sugarbaker’s Peritoneal Cancer Index for the Operability of Ovarian Carcinoma

P. Piso, P. Mallmann, D. Forner, 2015, International Journal of Gynecologic Cancer.

Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for limited peritoneal metastasis. The PSOGI international collaborative registry.

J. Esquivel, G. Salti, P. Piso, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced Recovery After Surgery (ERAS®) Society Recommendations - Part II: Postoperative management and special considerations.

B. Rau, M. Pocard, O. Sgarbura, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Consensus guidelines for pressurized intraperitoneal aerosol chemotherapy: Technical aspects and treatment protocols.

A. Nissan, M. Pocard, O. Sgarbura, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Therapeutic options for peritoneal metastasis arising from colorectal cancer.

H. Schlitt, P. Piso, G. Glockzin, 2016, World journal of gastrointestinal pharmacology and therapeutics.

Multimodality treatment strategies have changed prognosis of peritoneal metastases.

P. Piso, A. Mironiuc, V. Muntean, 2016, World journal of gastrointestinal oncology.

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis

M. Gerken, H. Schlitt, P. Piso, 2014, BMC Cancer.

Oxaliplatin-based versus irinotecan-based hyperther mic 1 intraperitoneal chemotherapy ( HIPEC ) in patients wi th 2 colorectal peritoneal metastasis : a retrospective a nalysis

M. Gerken, H. Schlitt, P. Piso, 2014 .

Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer

H. Schlitt, P. Piso, S. Lang, 2009, Journal of surgical oncology.

Evidence‐based medicine in the treatment of peritoneal carcinomatosis: Past, present, and future

A. Stojadinovic, A. Nissan, J. Esquivel, 2009, Journal of surgical oncology.

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

D. Morris, P. Piso, I. de Hingh, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

H. Schlitt, P. Piso, G. Glockzin, 2013, Journal of surgical oncology.

Treatment of peritoneal metastases from colorectal cancer

P. Piso, L. März, 2015, Gastroenterology report.

Results of Combined Gastrectomy and Pancreatic Resection in Patients with Advanced Primary Gastric Carcinoma

H. Schlitt, P. Piso, J. Klempnauer, 2002, Digestive Surgery.

Quality of life after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies

A. Nissan, H. Schlitt, P. Piso, 2009, Journal of surgical oncology.

Selection Criteria for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Special Emphasis on Laparoscopy as an Efficient Tool

P. Piso, H. Leebmann, Miklos Acs, 2022, In Vivo.

Follow-up tools and strategies after CRS and HIPEC for peritoneal surface malignancies

P. Piso, M. Mayr, H. Leebmann, 2014 .

Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional study

A. Stojadinovic, A. Nissan, T. Chua, 2010, Journal of surgical oncology.

Rare Histologies and Infrequent Indications for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

P. Piso, A. Szász, L. Halmy, 2022, AntiCancer Research.

Extraperitoneal Approach During Peritonectomy in the Right Upper Quadrant for Peritoneal Metastases from Ovarian Malignancies

P. Piso, P. Harter, S. Häusler, 2021, In Vivo.

Is there an oncological interest in the combination of CRS/HIPEC for peritoneal carcinomatosis of HCC? Results of a multicenter international study.

S. Msika, F. Guyon, B. Rau, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Challenges in the multidisciplinary management of stage IV colon and rectal cancer

P. Piso, D. Arnold, G. Glockzin, 2015, Expert review of gastroenterology & hepatology.

Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi‐institutional experience

M. Pocard, D. Morris, P. Piso, 2018, Journal of surgical oncology.

Complete versus incomplete cytoreduction in peritoneal carcinosis from gastric cancer, with consideration to PCI cut-off. Systematic review and meta-analysis.

P. Piso, L. Ansaloni, P. Sugarbaker, 2015, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

H. Schlitt, P. Piso, J. Klempnauer, 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Proximal Versus Distal Gastric Carcinoma—What Are the Differences?

P. Piso, J. Klempnauer, H. Lang, 2000, Annals of Surgical Oncology.

Management and results of proximal anastomotic leaks in a series of 1114 total gastrectomies for gastric carcinoma.

P. Piso, H. Lang, R. Raab, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Differences in attitude toward living and postmortal liver donation in the United States, Germany, and Japan.

H. Schlitt, P. Piso, F. Popp, 2005, Psychosomatics.

Pancreatogastrostomy Versus Pancreatojejunostomy for RECOnstruction After PANCreatoduodenectomy (RECOPANC, DRKS 00000767)

U. Neumann, J. Izbicki, W. Uhl, 2016, Annals of surgery.

High molecular weight adiponectin reduces apolipoprotein B and E release in human hepatocytes.

T. Langmann, J. Schölmerich, G. Schmitz, 2007, Biochemical and biophysical research communications.

Immunomodulatory Effects of Mesenchymal Stem Cells in a Rat Organ Transplant Model

G. Koehl, E. Geissler, H. Schlitt, 2006, Transplantation.

Antigen-specific recognition is critical for the function of regulatory CD8(+)CD28(-) T cells.

E. Geissler, P. Piso, E. Eggenhofer, 2010, Transplant immunology.

Current status and future directions in gastric cancer with peritoneal dissemination.

P. Piso, G. Glockzin, 2012, Surgical oncology clinics of North America.

Importance and Qualitative Requirements of Magnetic Resonance Imaging for Therapy Planning in Rectal Cancer - Interdisciplinary Recommendations of AIO, ARO, ACO and the German Radiological Society.

G. Antoch, A. Schreyer, S. Clasen, 2020, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Mesenteric Ischemia – Outcome after Surgical Therapy in 83 Patients

O. Stoeltzing, S. Feuerbach, P. Piso, 2008, Digestive Surgery.

Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details

P. Piso, T. Boerner, 2021, Journal of clinical medicine.

A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern Germany

M. Gerken, H. Schlitt, P. Piso, 2011, International Journal of Colorectal Disease.

Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–-Overview and Basics

A. Nissan, J. Esquivel, D. Bartlett, 2012, Cancer investigation.

Patients with Metachronous Peritoneal Metastatic Mucinous Colorectal Adenocarcinoma Benefit More from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) than Their Synchronous Counterparts

P. Piso, A. Szász, M. Dank, 2022, Cancers.

Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

M. Gerken, P. Piso, J. Zustin, 2022, Langenbeck's Archives of Surgery.

Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Doxorubicin for 90 Minutes Versus 60 Minutes After Cytoreductive Surgery (CRS). Does the 30-Minute Difference Matter? A Comparative Study in a High Volume Centre

M. Gerken, P. Piso, Miklos Acs, 2022, AntiCancer Research.

Prolonged Exposition with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) May Provide Survival Benefit after Cytoreductive Surgery (CRS) in Advanced Primary Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

P. Piso, A. Szász, S. Häusler, 2022, Cancers.

The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: A web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI).

B. Rau, D. Morris, P. Piso, 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The Characteristics of 206 Long-Term Survivors with Peritoneal Metastases from Colorectal Cancer Treated with Curative Intent Surgery: A Multi-Center Cohort from PSOGI

B. Rau, P. Piso, S. Ishihara, 2021, Cancers.

Intraperitoneale intraoperative Chemotherapie (HIPEC/PIPAC)

J. Kleeff, D. Strumberg, P. Piso, 2021, Springer Reference Medizin.

Cytoreductive surgery and HIPEC improve survival compared to palliative chemotherapy for biliary carcinoma with peritoneal metastasis: A multi-institutional cohort from PSOGI and BIG RENAPE groups.

B. Rau, S. Ahrendt, M. Pocard, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Benefit of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with isolated peritoneal metastases from colorectal cancer

M. Gerken, P. Piso, M. Klinkhammer-Schalke, 2018, International Journal of Colorectal Disease.

[Peritoneal carcinomatosis. Surgical treatment, including hyperthermal intraperitoneal chemotherapy].

A. Agha, H. Schlitt, P. Piso, 2007, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Patient Selection for a Curative Approach to Carcinomatosis

J. Esquivel, H. Schlitt, P. Piso, 2009, Cancer journal.

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2007, Annals of Surgical Oncology.

Surgical Approach Including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients with Peritoneal Metastasis

H. Schlitt, P. Piso, G. Glockzin, 2013, Visceral Medicine.

Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

H. Schlitt, P. Piso, G. Glockzin, 2009, World journal of surgical oncology.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

H. Schlitt, P. Piso, M. Dahlke, 2004, World journal of surgical oncology.

Indication of CRS and HIPEC in Peritoneal Metastases of NET and Small Intestine Carcinomas

P. Piso, H. Leebmann, 2021 .

Mesenchymal stem cells together with mycophenolate mofetil inhibit antigen presenting cell and T cell infiltration into allogeneic heart grafts.

E. Geissler, P. Piso, E. Eggenhofer, 2011, Transplant immunology.

Rare diaphragmatic complications following cytoreductive surgery and HIPEC: report of two cases

P. Piso, M. Mayr, H. Leebmann, 2014, Surgery Today.

Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei

H. Schlitt, P. Piso, J. Klempnauer, 2005, International Journal of Colorectal Disease.

Toward MSC in Solid Organ Transplantation: 2008 Position Paper of the MISOT Study Group

N. Perico, G. Remuzzi, H. Verspaget, 2009, Transplantation.

Childbearing After Hyperthermic Intraperitoneal Chemotherapy: Results From an International Survey

P. Piso, E. Levine, P. Sugarbaker, 2011, Annals of Surgical Oncology.

Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.

O. Stoeltzing, E. Geissler, H. Schlitt, 2007, Experimental hematology.

Mesenchymal Stem Cells Can Affect Solid Organ Allograft Survival

E. Geissler, H. Schlitt, P. Piso, 2009, Transplantation.

Treatment Options for Peritoneal Tumor Recurrence

P. Piso, H. Leebmann, 2021 .

An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

S. Msika, F. Guyon, B. Rau, 2022, World Journal of Surgery.

Is the Combination of Distal Pancreatectomy and Cytoreductive Surgery With HIPEC Reasonable?: Results of an International Multicenter Study

D. Morris, P. Piso, E. Levine, 2016, Annals of surgery.

Which patient is going to benefit from surgical cytoreduction with intraperitoneal chemotherapy (for manifest peritoneal metastases)?

P. Piso, S. Blaj, 2017 .

Safety of Gastric Resections During Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis

H. Schlitt, P. Piso, F. Popp, 2009, Annals of Surgical Oncology.

Perioperative management of patients with cytoreductive surgery for peritoneal carcinomatosis

Wiley Interscience, P. Piso, S. Moritz, 2009, Journal of surgical oncology.

Peri‐operative anaesthetic management of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy

P. Piso, M. Creutzenberg, J. Hobbhahn, 2008, Anaesthesia.

Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate.

E. Geissler, P. Piso, E. Eggenhofer, 2008, Transplant immunology.

Intraabdominal septic complications following bowel resection for Crohn’s disease: detrimental influence on long-term outcome

F. Klebl, A. Agha, H. Schlitt, 2008, International Journal of Colorectal Disease.

CRS-HIPEC Prolongs Survival but is Not Curative for Patients with Peritoneal Carcinomatosis of Gastric Cancer

H. Schlitt, P. Piso, M. Dahlke, 2016, Annals of Surgical Oncology.

Mesenchymal stem cells require a sufficient, ongoing immune response to exert their immunosuppressive function.

E. Geissler, H. Schlitt, P. Piso, 2009, Transplantation proceedings.

A comprehensive treatment for peritoneal metastases from gastric cancer with curative intent.

D. Morris, P. Piso, D. Elias, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Mesenchymal stem cells as immunomodulators after liver transplantation

E. Geissler, H. Schlitt, P. Piso, 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Ten-year single-center experience with treatment of primary diffuse malignant peritoneal mesothelioma (DMPM) by cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

M. Gerken, P. Piso, J. Zustin, 2022, Langenbeck's Archives of Surgery.

Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care

P. Piso, E. Levine, R. McQuellon, 2008, Journal of surgical oncology.

5-Fluorouracil-related enhancement of adenoviral infection is Coxsackievirus-adenovirus receptor independent and associated with morphological changes in lipid membranes.

H. Schlitt, P. Piso, K. Jauch, 2006, World journal of gastroenterology.

Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer.

P. Piso, D. Arnold, 2011, Deutsches Arzteblatt international.

Hepatobiliary Procedures in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

H. Schlitt, P. Piso, F. Popp, 2011, Annals of Surgical Oncology.

Two decades of multimodality treatment for peritoneal surface malignancies: A tribute to the pioneers of this field

A. Nissan, P. Piso, 2009, Journal of surgical oncology.

Pleura and Peritoneum

B. Rau, W. Bechstein, S. Mönig, 2018 .

Clinical outcome after total neoadjuvant treatment (CAO/ARO/AIO-12) versus intensified neoadjuvant and adjuvant treatment (CAO/ARO/AIO-04) A comparison between two multicenter randomized phase II/III trials.

R. Grützmann, C. Rödel, E. Fokas, 2022, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Is treatment in certified cancer centers related to better survival in patients with pancreatic cancer? Evidence from a large German cohort study

M. Gerken, V. Bierbaum, P. Piso, 2022, BMC cancer.

Intestinal ischemia: current treatment concepts

H. Schlitt, P. Piso, C. Stroszczynski, 2010, Langenbeck's Archives of Surgery.

Delayed Visceral Arterial Hemorrhage Following Whipple’s Procedure: Minimally Invasive Treatment with Covered Stents

H. Schlitt, P. Piso, S. Feuerbach, 2008, Annals of Surgical Oncology.

Best practice for perioperative management of patients with cytoreductive surgery and HIPEC.

P. Piso, L. Flöther, M. Bucher, 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Targeting Heat Shock Protein 90 in Pancreatic Cancer Impairs Insulin-like Growth Factor-I Receptor Signaling, Disrupts an Interleukin-6/Signal-Transducer and Activator of Transcription 3/Hypoxia-Inducible Factor-1α Autocrine Loop, and Reduces Orthotopic Tumor Growth

O. Stoeltzing, A. Gaumann, E. Geissler, 2007, Clinical Cancer Research.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

T. Chua, D. Morris, P. Piso, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of HIPEC after Complete Cytoreductive Surgery (CRS) in Peritoneal Recurrence of Platinum-Sensitive Recurrent Ovarian Cancer (OC): The Aim for Standardization at Two Reference Centers for CRS

M. Gerken, P. Piso, C. Yurttas, 2023, Cancers.

Guidelines for Perioperative Care in Cytoreductive Surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): Enhanced recovery after surgery (ERAS®) Society Recommendations - Part I: Preoperative and intraoperative management.

B. Rau, M. Pocard, O. Sgarbura, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

S3-Leitlinie „Magenkarzinom” –

M. Ebert, H. Feußner, P. Malfertheiner, 2011 .

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

T. Chua, J. Pelz, D. Morris, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prolonged Survival in Peritoneal Metastatic Appendiceal Carcinoma Patients Treated With Combined Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

M. Gerken, P. Piso, J. Zustin, 2023, The Journal of surgical research.

Metastatic Colorectal Cancer to the Peritoneum: Current Treatment Options

P. Piso, N. Vassos, 2018, Current Treatment Options in Oncology.

No Contribution of Multipotent Mesenchymal Stromal Cells to Liver Regeneration in a Rat Model of Prolonged Hepatic Injury

O. Stoeltzing, E. Geissler, H. Schlitt, 2007, Stem cells.

Diagnosing deficits in quality of life and providing tailored therapeutic options: Results of a randomised trial in 220 patients with colorectal cancer.

M. Koller, P. Piso, R. Obermaier, 2020, European journal of cancer.

Liver regeneration in a retrorsine/CCl4-induced acute liver failure model: do bone marrow-derived cells contribute?

H. Schlitt, P. Piso, J. Klempnauer, 2003, Journal of hepatology.

Prognostic significance of calcium-binding protein S100A4 in colorectal cancer.

H. Kreipe, Gerrit Peters, Silvia Gongoll, 2002, Gastroenterology.

Improved prognosis following peritonectomy procedures and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis from appendiceal carcinoma.

M. Manns, S. Kubicka, H. Schlitt, 2001, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[Diagnosis of and therapy for gastric cancer--work-flow].

M. Hünerbein, A. Hölscher, C. Rödel, 2009, Zentralblatt fur Chirurgie.

Effect of intraperitoneal chemotherapy and peritoneal lavage in positive peritoneal cytology in gastric cancer. Systematic review and meta-analysis.

P. Piso, L. Ansaloni, P. Sugarbaker, 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Risk stratification for postoperative pancreatic fistula using the pancreatic surgery registry StuDoQ|Pancreas of the German Society for General and Visceral Surgery.

J. D'haese, H. Friess, R. Grützmann, 2019, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2006, Annals of Surgical Oncology.

Re-operations for early postoperative complications after CRS and HIPEC: indication, timing, procedure, and outcome

D. Leucuta, P. Piso, M. Mayr, 2019, Langenbeck's Archives of Surgery.

Quality of Life and Functional Long-Term Outcome After Partial Pancreatoduodenectomy: Pancreatogastrostomy Versus Pancreatojejunostomy

P. Piso, J. Klempnauer, U. Schmidt, 2005, Annals of Surgical Oncology.

Particularities of anesthesia and postoperative intensive care related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

H. Schlitt, P. Piso, B. Graf, 2009 .

The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery.

J. Pelz, D. Morris, P. Piso, 2021, JAMA surgery.

Current Status of Metastatic Cardiophrenic Lymph Nodes (CPLNs) in Patients With Ovarian Cancer: A Review

P. Piso, S. Prader, Miklos Acs, 2021, AntiCancer Research.

Conversion rate in 300 laparoscopic rectal resections and its influence on morbidity and oncological outcome

A. Agha, H. Schlitt, P. Piso, 2008, International Journal of Colorectal Disease.

Morbidity and Mortality Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Data from the DGAV StuDoQ Registry with 2149 Consecutive Patients

B. Rau, P. Piso, A. Königsrainer, 2018, Annals of Surgical Oncology.

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience

M. Pocard, D. Morris, P. Piso, 2018, Annals of Surgical Oncology.

American Society of peritoneal surface malignancies opinion statement on defining expectations from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with colorectal cancer

J. Pelz, J. Esquivel, P. Piso, 2014, Journal of surgical oncology.

[Is liver resection in metastases of exocrine pancreatic carcinoma justified?].

P. Piso, R. Pichlmayr, G. Ridder, 1996, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

Intraoperative (hyperthermic) intraperitoneal chemotherapy – Considerations and aspects for the safe intra- and postoperative use of cytostatic agents

P. Piso, R. Pichlmayr, J. Jähne, 1997 .

Results of Palliative Resections for Gastric Carcinoma

P. Piso, H. Meyer, J. Jähne, 1998, Oncology Research and Treatment.

Retroperitoneoscopic adrenalectomy: Lateral versus dorsal approach

A. Agha, H. Schlitt, P. Piso, 2008, Journal of surgical oncology.

Continuous peritoneal perfusion: techniques, methods and applications.

H. Schlitt, P. Piso, M. Dahlke, 2007, Cancer treatment and research.

Prevention of Peritoneal Carcinomatosis from Human Gastric Cancer Cells by Adjuvant-Type Intraperitoneal Immunotherapy in a SCID Mouse Model

H. Schlitt, P. Piso, J. Klempnauer, 2003, European Surgical Research.

Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells

E. Geissler, H. Schlitt, P. Piso, 2016, Oncoimmunology.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of Surgical Oncology.

L. Oñate-Ocaña, N. Petrelli, D. Shibata, 2007, Annals of surgical oncology.

Peritoneal metastasis in gastric cancer: results from the German database

M. Hünerbein, B. Rau, P. Busch, 2019, Gastric Cancer.

A narrative review of intraperitoneal chemotherapy and cytoreductive surgery (CRS) for peritoneal metastases in gastric cancer.

P. Piso, T. Boerner, 2020, Journal of gastrointestinal oncology.

Immune-mediated hepatitis drives low-level fusion between hepatocytes and adult bone marrow cells.

R. Loi, H. Schlitt, P. Piso, 2006, Journal of hepatology.

High volume naked DNA tail‐vein injection restores liver function in Fah‐knock out mice

E. Geissler, P. Piso, E. Eggenhofer, 2010, Journal of gastroenterology and hepatology.

1114 total gastrectomies in the surgical treatment of primary gastric adenocarcinoma--a 30-year single institution experience.

P. Piso, H. Meyer, J. Jähne, 2001, Hepato-gastroenterology.

Prognostic Factors in Pseudomyxoma Peritonei with Emphasis on the Predictive Role of Peritoneal Cancer Index and Tumor Markers

Z. Lohinai, H. Schlitt, P. Piso, 2023, Cancers.

Characterization of microvascularization of liver tumor lesions with high resolution linear ultrasound and contrast enhanced ultrasound (CEUS) during surgery: First results.

E. Jung, A. Schreyer, P. Lamby, 2010, Clinical hemorheology and microcirculation.

Early gastric cancer – excellent prognosis after curative resection in 87 patients irrespective of submucosal infiltration, lymph-node metastases or tumor size

P. Piso, D. Benten, J. Klempnauer, 2001, Langenbeck's Archives of Surgery.

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

M. Koller, F. Klebl, H. Schlitt, 2013, BMC Cancer.

A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

F. Klebl, H. Schlitt, P. Piso, 2013, BMC Cancer.

Surgical therapy of gastric stump carcinoma--a retrospective analysis of 109 patients.

P. Piso, H. Meyer, J. Jähne, 1999, Hepato-gastroenterology.

Hypertherme intraperitoneale Chemotherapie

P. Piso, H. Leebmann, P. D. P. Piso, 2019, Der Chirurg.

Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC).

D. Nowak, P. Piso, J. Novotná, 2012, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Feasibility and safety of PIPAC combined with additional surgical procedures: PLUS study.

A. Nissan, M. Pocard, O. Sgarbura, 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: first results of a new German centre for peritoneal surface malignancies

A. Agha, H. Schlitt, P. Piso, 2007, International Journal of Colorectal Disease.

Current practice and perceptions of safety protocols for the use of intraperitoneal chemotherapy in the operating room: results of the IP-OR international survey

B. Rau, O. Sgarbura, M. Hübner, 2021, Pleura and Peritoneum.

[Recent Developments in the Regional Treatment of Peritoneal and Pleural Tumours (incl. HIPEC and HITOC)].

P. Piso, H. Hofmann, 2019, Zentralblatt für Chirurgie.

An Invasive Treatment of Pseudomyxoma Peritonei with Intrathoracic Involvement.

P. Piso, G. Samașca, C. Burz, 2016, Maedica.

Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial

M. Koller, B. Rau, H. Schlitt, 2018, Clinical colorectal cancer.

Procedures of Parietal and Visceral Peritonectomy of the Upper Abdomen

P. Piso, H. Leebmann, 2021 .

1376O The effect of hyperthermic intraperitoneal chemotherapy (HIPEC) upon cytoreductive surgery (CRS) in gastric cancer (GC) with synchronous peritoneal metastasis (PM): A randomized multicentre phase III trial (GASTRIPEC-I-trial)

V. Heinemann, T. Keck, P. Piso, 2021, Annals of Oncology.

Prospective Registry On Mesothelioma Peritonei Treatment (PROMPT): study design and rationale.

S. Laurberg, J. Esquivel, D. Morris, 2012, Tumori.

Malignant Struma Ovarii Τreated With Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

P. Piso, J. Zustin, S. Häusler, 2021, In Vivo.

Total Neoadjuvant Therapy for Rectal Cancer in the CAO/ARO/AIO-12 Randomized Phase 2 Trial: Early Surrogate Endpoints Revisited

C. Rödel, W. Bechstein, E. Fokas, 2022, Cancers.

Radiotherapy dose escalation using endorectal brachytherapy in elderly and frail patients with rectal cancer unsuitable for surgery: Lessons from studies in fit patients and future perspectives.

C. Rödel, E. Fokas, R. Hofheinz, 2022, Cancer treatment reviews.

Total mesorectal excision for middle and lower rectal cancer: A single institution experience with 337 consecutive patients

H. Schlitt, P. Piso, M. Dahlke, 2004, Journal of surgical oncology.

The peritoneum, a still neglected organ. Its rediscovery through a new scientific journal: the Journal of Peritoneum (and other serosal surfaces)

P. Piso, L. Ansaloni, 2016 .

Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis

M. Gerken, H. Schlitt, P. Piso, 2014, BMC Cancer.

Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases

P. Piso, P. Sánchez-Velázquez, M. Dank, 2023, World journal of gastroenterology.

Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

W. Bechstein, S. Mönig, P. Piso, 2021, BMC Cancer.

[Specific treatment situations in metastatic colorectal cancer].

H. Amthauer, T. Seufferlein, W. Knoefel, 2010, Onkologie.

Indications for CRS and HIPEC in Peritoneal Metastases from Colorectal Carcinoma

P. Piso, F. Quénet, L. März, 2021 .

Early postoperative CRP predicts major complications following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)

P. Piso, P. Starlinger, T. Bachleitner-Hofmann, 2023, Pleura and peritoneum.

[S3 guidelines on gastric cancer-diagnosis and treatment of adenocarcinoma of the stomach and esophagogastric junction : Version 2.0-August 2019. AWMF register number: 032/009OL].

D. Lorenz, S. Mönig, P. Piso, 2020, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.

["Fast-Track" for laparoscopic-assisted rectum resection--what can be achieved? First results of a feasibility study].

A. Agha, H. Schlitt, P. Piso, 2006, Zentralblatt fur Chirurgie.

Effects of the Pandemic on the Care of Patients With Colorectal Cancer.

M. Ebert, P. Piso, D. Hüppe, 2023, Deutsches Arzteblatt international.

Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.

M. Simone, A. Nissan, M. Pocard, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Appendiceal tumours and pseudomyxoma peritonei: Literature review with PSOGI/EURACAN clinical practice guidelines for diagnosis and treatment.

M. Simone, A. Nissan, B. Rau, 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The Delphi and GRADE methodology used in the PSOGI 2018 consensus statement on Pseudomyxoma Peritonei and Peritoneal Mesothelioma.

M. Simone, A. Nissan, J. Burger, 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Allogeneic bone marrow transplantation restores liver function in Fah-knockout mice.

E. Geissler, H. Schlitt, P. Piso, 2008, Experimental hematology.

Treatment of peritoneal metastases from colorectal cancer

P. Piso, L. März, 2015, Gastroenterology report.

Multimodal treatment approaches for peritoneal carcinosis in colorectal cancer.

P. Piso, D. Arnold, 2011, Deutsches Arzteblatt international.

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI).

P. Piso, J. Spiliotis, P. Sugarbaker, 2018, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

“En bloc” caudate lobe and inferior vena cava resection following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal and liver metastasis of colorectal cancer

P. Piso, P. Sánchez-Velázquez, I. Töpel, 2016, World journal of gastroenterology.

Mesenteric Ischemia – Outcome after Surgical Therapy in 83 Patients

O. Stoeltzing, S. Feuerbach, P. Piso, 2008, Digestive Surgery.

Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases From a Small Bowel Adenocarcinoma: Multi-Institutional Experience

M. Pocard, D. Morris, P. Piso, 2018, Annals of Surgical Oncology.

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer

H. Schlitt, P. Piso, M. Dahlke, 2004, World journal of surgical oncology.

A novel tumor‐node‐metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi‐institutional database *

T. Chua, D. Morris, P. Piso, 2011, Cancer.

Effectiveness of Peripheral Hepatogastrostomy Versus Hepatojejunostomy in the Treatment of Obstructive Cholestasis: Results of an Experimental Model

P. Flemming, H. Schlitt, P. Piso, 2004, Surgery Today.

Mesenchymal Stem Cells Can Affect Solid Organ Allograft Survival

E. Geissler, H. Schlitt, P. Piso, 2009, Transplantation.

Therapeutic potential of bone marrow stem cells for liver diseases.

H. Schlitt, P. Piso, F. Popp, 2006, Current stem cell research & therapy.

Peritoneal metastasis in gastric cancer: results from the German database

M. Hünerbein, B. Rau, P. Busch, 2019, Gastric Cancer.

Laparoscopic cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Long term oncologic outcomes from the international PSOGI registry.

J. Esquivel, G. Salti, O. Sgarbura, 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Reply to M. Markman

D. Morris, P. Piso, D. Elias, 2010 .

Peritoneal Carcinomatosis: Cytoreductive Surgery and HIPEC–-Overview and Basics

A. Nissan, J. Esquivel, D. Bartlett, 2012, Cancer investigation.

Autofluorescent Imaging in Patients With Peritoneal Carcinomatosis

A. Agha, H. Schlitt, P. Piso, 2014, Surgical innovation.